Immunohistochemical Analysis Still Has a Limited Role in the Diagnosis of Malignant Mesothelioma
Open Access
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (2) , 253-262
- https://doi.org/10.1309/xl6k-8e62-9fld-v8q8
Abstract
To identify the most accurate and useful panel to diagnose mesothelioma, we immunostained sections from 112 mesotheliomas, 18 adenocarcinomas, and 11Keywords
This publication has 30 references indexed in Scilit:
- Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the PleuraLaboratory Investigation, 2000
- Synovialsarkom des PerikardsDer Pathologe, 1998
- HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.Journal of Clinical Pathology, 1997
- CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinomaHistopathology, 1997
- MesotheliomaThe Lancet, 1995
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- Immunoreactivity for p‐170 glycoprotein in malignant mesothelioma and in non‐neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB‐1The Journal of Pathology, 1992
- The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 casesHistopathology, 1990
- Diffuse malignant pleural mesothelioma in glasglowRespiratory Medicine, 1981
- Absence of carcinoembryonic antigen-like material in mesotheliomaAn immunohistochemical differentiation from other lung cancersCancer, 1979